Gender Differences and 10-Year Prognosis in STEMI

Coronary artery disease in women usually develops 10 years later than in men, and some evidence suggests women have higher mortality, especially when it comes to ST elevation MI (STEMI). Registries have shown higher mortality both in hospital and at one year follow up. 

Diferencia de género y pronostico a 10 años en el síndrome coronario con elevación del ST

In part, this difference is observed because of the gap in therapy access, such as angiography studies or PCI procedures during an acute coronary syndrome. 

The aim of this study was to analyze the impact of gender in 10-year outcomes of STEMI patients treated with percutaneous coronary intervention (PCI) in the EXAMINATION-EXTEND study (use of XIENCE stent in STEMI).

Study outcomes were a patient oriented combined end point (POCE) which included all-cause mortality, any MI or revascularization at 10 years. 

Data from 1498 patients were obtained, 254 women (17%). Women were generally older, fewer smoked and they had more hypertension.  

At 10-year follow-up, we observed the presence of POCE in 40.6% of women and 34.2% of men (adjusted HR, 1.14, CI 95% 0.91-1.42; P=0.259), with a tendency towards higher all-cause mortality in women (adjusted HR: 1.30, CI 95% 0.99-1.71; P=0.063). However, cardiovascular death did not vary between the groups. 

Read also: RADIANCE-HTN SOLO: Control Durability of BP

At multivariable analysis, only age (HR: 1.06, CI 95% 1.04-1.09; P<0.001) and hypertension (HR: 1.93, CI 95% 1.07-3.51; P=0.030) were independent predictors of POCE.  

Conclusions

At 10-year follow-up of ACS patients, we saw women with STEMI did not have a worse prognosis as regards 10-year POCE, compared against men. Although there was a tendency toward higher mortality, there was no difference when it came to cardiac mortality. 

Being able to look at 10-year data offers a great opportunity for gender based long term risk assessment. There is a sample limitation of only 17% of women, which means these conclusions will only serve as hypotheses generator. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original title: Gender Differences in 10-Year Outcomes Following STEMI.

Source: Rader, Florian et al. “Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial.” EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, EIJ-D-22-00305. 1 Aug. 2022, doi:10.4244/EIJ-D-22-00305.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...